What is Behind Beijing Chunlizhengda Medical Instruments Co Ltd’s (HKG:1858) Superior ROE?

In This Article:

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business. To keep the lesson grounded in practicality, we’ll use ROE to better understand Beijing Chunlizhengda Medical Instruments Co Ltd (HKG:1858).

Beijing Chunlizhengda Medical Instruments has a ROE of 15%, based on the last twelve months. That means that for every HK$1 worth of shareholders’ equity, it generated HK$0.15 in profit.

Check out our latest analysis for Beijing Chunlizhengda Medical Instruments

How Do I Calculate Return On Equity?

The formula for return on equity is:

Return on Equity = Net Profit ÷ Shareholders’ Equity

Or for Beijing Chunlizhengda Medical Instruments:

15% = CN¥83m ÷ CN¥573m (Based on the trailing twelve months to June 2018.)

It’s easy to understand the ‘net profit’ part of that equation, but ‘shareholders’ equity’ requires further explanation. It is all the money paid into the company from shareholders, plus any earnings retained. Shareholders’ equity can be calculated by subtracting the total liabilities of the company from the total assets of the company.

What Does Return On Equity Signify?

ROE looks at the amount a company earns relative to the money it has kept within the business. The ‘return’ is the yearly profit. That means that the higher the ROE, the more profitable the company is. So, all else equal, investors should like a high ROE. That means it can be interesting to compare the ROE of different companies.

Does Beijing Chunlizhengda Medical Instruments Have A Good ROE?

By comparing a company’s ROE with its industry average, we can get a quick measure of how good it is. Importantly, this is far from a perfect measure, because companies differ significantly within the same industry classification. As is clear from the image below, Beijing Chunlizhengda Medical Instruments has a better ROE than the average (9.7%) in the medical equipment industry.

SEHK:1858 Last Perf October 11th 18
SEHK:1858 Last Perf October 11th 18

That’s clearly a positive. We think a high ROE, alone, is usually enough to justify further research into a company. One data point to check is if insiders have bought shares recently.

The Importance Of Debt To Return On Equity

Most companies need money — from somewhere — to grow their profits. That cash can come from retained earnings, issuing new shares (equity), or debt. In the case of the first and second options, the ROE will reflect this use of cash, for growth. In the latter case, the debt required for growth will boost returns, but will not impact the shareholders’ equity. In this manner the use of debt will boost ROE, even though the core economics of the business stay the same.